These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29289609)

  • 21. Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study.
    Xu Y; Wang Y; Liu H; Kang X; Li W; Wei Q
    Oncotarget; 2016 Sep; 7(38):61716-61727. PubMed ID: 27557513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A functional polymorphism on chromosome 15q25 associated with survival of early stage non-small-cell lung cancer.
    Jin G; Bae EY; Yang E; Lee EB; Lee WK; Choi JE; Jeon HS; Yoo SS; Lee SY; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
    J Thorac Oncol; 2012 May; 7(5):808-14. PubMed ID: 22722785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variants of
    Lu G; Liu H; Wang H; Tang X; Luo S; Du M; Christiani DC; Wei Q
    Front Immunol; 2024; 15():1455927. PubMed ID: 39416786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.
    Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
    Int J Cancer; 2020 Jul; 147(2):392-403. PubMed ID: 31618441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer.
    Lee SY; Jung DK; Choi JE; Jin CC; Hong MJ; Do SK; Kang HG; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Park JY
    Gene; 2017 Jan; 599():28-35. PubMed ID: 27838455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of CASP7 polymorphisms and survival of patients with non-small cell lung cancer with platinum-based chemotherapy treatment.
    Qian J; Gu S; Wu Q; Zhao X; Wu W; Gao Z; Zhang W; Tan X; Wang H; Wang J; Fan W; Chen H; Han B; Lu D; Wei Q; Jin L
    Chest; 2012 Sep; 142(3):680-689. PubMed ID: 22441531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC.
    Uzunoglu FG; Yavari N; Bohn BA; Nentwich MF; Reeh M; Pantel K; Perez D; Tsui TY; Bockhorn M; Mann O; Izbicki JR; Wikman H; Vashist YK
    Lung Cancer; 2013 Jul; 81(1):123-9. PubMed ID: 23548249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid Metabolism Pathway Genes and Lung Cancer: ACADSB rs12220683G>C Is Associated with Better Survival Outcome in Patients with Non-Small Cell Lung Cancer.
    Yoo SS; Do SK; Choi JE; Kang HG; Hong MJ; Lee JH; Lee WK; Do YW; Lee EB; Park JE; Choi SH; Seo H; Lee YH; Lee J; Lee SY; Cha SI; Kim CH; Park JY
    Oncology; 2024; 102(1):67-75. PubMed ID: 37527640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.
    Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
    Cancer Immunol Immunother; 2021 Oct; 70(10):2819-2833. PubMed ID: 33651148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentially functional variants of
    Lu G; Liu H; Wang H; Tang X; Luo S; Du M; Christiani DC; Wei Q
    Front Immunol; 2024; 15():1440454. PubMed ID: 39176091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.
    Wu Y; Liu Z; Tang D; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Lin L; Christiani DC; Wang Q; Wei Q
    Transl Res; 2021 Jul; 233():92-103. PubMed ID: 33400994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype.
    Tseden-Ish M; Choi YD; Cho HJ; Ban HJ; Oh IJ; Kim KS; Song SY; Na KJ; Ahn SJ; Choi S; Kim YC
    Respirology; 2012 Jan; 17(1):127-33. PubMed ID: 21899657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single nucleotide polymorphisms in tobacco metabolism and DNA repair genes and prognosis in resected non-small-cell lung cancer.
    Campayo M; Viñolas N; Navarro A; Carcereny E; Casas F; Gel B; Diaz T; Gimferrer JM; Marrades RM; Ramirez J; Monzo M
    J Surg Res; 2011 May; 167(1):e5-12. PubMed ID: 21324488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.
    Glubb DM; Paré-Brunet L; Jantus-Lewintre E; Jiang C; Crona D; Etheridge AS; Mirza O; Zhang W; Seiser EL; Rzyman W; Jassem J; Auman T; Hirsch FR; Owzar K; Camps C; Dziadziuszko R; Innocenti F
    J Thorac Oncol; 2015 Jul; 10(7):1067-75. PubMed ID: 26134224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer.
    Xu J; Tian S; Yin Z; Wu S; Liu L; Qian Y; Pei D; Gao W; Xu J; Yin Y; Liu P; Shu Y
    Lung Cancer; 2014 Sep; 85(3):442-8. PubMed ID: 24997136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional intronic variant of SLC5A10 affects DRG2 expression and survival outcomes of early-stage non-small-cell lung cancer.
    Hong MJ; Yoo SS; Choi JE; Kang HG; Do SK; Lee JH; Lee WK; Lee J; Lee SY; Cha SI; Kim CH; Lee EB; Cho S; Jheon S; Park JY
    Cancer Sci; 2018 Dec; 109(12):3902-3909. PubMed ID: 30281872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients.
    Vasile E; Tibaldi C; Leon GL; D'Incecco A; Giovannetti E
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1189-94. PubMed ID: 25504507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
    Li J; Shi SB; Shi WL; Wang Y; Yu LC; Zhu LR; Ge LP
    Transl Res; 2014 Jan; 163(1):27-35. PubMed ID: 24120632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer--a pilot study.
    Krawczyk P; Wojas-Krawczyk K; Mlak R; Kucharczyk T; Biernacka B; Milanowski J
    Folia Histochem Cytobiol; 2012 Apr; 50(1):80-6. PubMed ID: 22532140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.